Suven Life Sciences Ltd
NSE: SUVEN BSE: 530239
₹210.18
(7.19%)
Thu, 23 Apr 2026, 10:33 pm
Market Cap51.66B
PE Ratio0
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KSuven Life Sciences Financials
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 880.78M | 1.12B | 1.17B | 1.40B | 1.29B | 1.50B | 2.04B | 2.58B | 5.10B | 5.21B | 5.00B | 5.39B | 6.13B | 2.76B | 144.15M | 134.78M | 118.44M | 135.39M | 116.93M | 66.56M |
| Gross profit | 374.77M | 324.04M | 466.99M | 429.78M | 538.71M | 513.76M | 716.69M | 1.00B | 2.76B | 2.13B | 1.93B | 2.26B | 2.84B | 1.06B | -88.18M | -94.28M | -137.31M | -119.93M | -147.72M | -213.26M |
| Operating expenses (excl. COGS) | -298.54M | -11.18M | -386.03M | -306.66M | -444.51M | -432.59M | -447.27M | -511.04M | -654.02M | -652.59M | -1.08B | -1.20B | -1.16B | -1.34B | -1.08B | -744.45M | -1.12B | -1.20B | -1.20B | -1.50B |
| Selling/general/admin expenses, total | -297.34M | — | -383.98M | — | -441.00M | -430.73M | -432.72M | -508.70M | -636.33M | -630.24M | -1.07B | -1.19B | -1.16B | -1.34B | -1.06B | -744.45M | -1.12B | -1.20B | -1.20B | -1.50B |
| Research & development | -182.99M | -190.02M | -201.69M | -294.60M | -341.51M | -311.44M | -330.49M | -320.94M | -452.95M | -435.26M | -838.96M | -929.12M | -867.62M | -1.16B | -1.19B | -863.55M | -1.25B | -1.36B | -1.35B | -1.67B |
| Selling/general/admin expenses, other | -114.35M | — | -182.29M | — | -99.49M | -119.30M | -102.23M | -187.76M | -183.37M | -194.97M | -231.88M | -257.55M | -289.86M | -182.93M | 128.50M | 119.10M | 124.03M | 158.08M | 158.69M | 167.04M |
| Other operating expenses, total | -1.20M | -11.18M | -2.05M | -306.66M | -3.51M | -1.86M | -14.55M | -2.34M | -17.69M | -22.35M | -5.66M | -11.61M | -5.36M | 1.63M | -17.87M | 0 | -88.00K | -1.33M | -76.00K | -98.00K |
| Operating income | 76.23M | 122.84M | 80.96M | 123.12M | 94.20M | 81.17M | 269.42M | 492.12M | 2.10B | 1.48B | 856.46M | 1.06B | 1.68B | -280.86M | -1.17B | -838.73M | -1.26B | -1.32B | -1.34B | -1.71B |
| Non-operating income, total | -11.81M | -16.54M | -18.89M | -73.31M | -57.14M | -48.62M | -178.00M | -163.59M | -77.16M | 36.05M | 119.38M | 176.25M | 280.05M | 282.42M | 106.03M | 63.99M | 41.92M | 137.07M | 282.18M | 105.04M |
| Interest expense, net of interest capitalized | -12.98M | -23.38M | -45.71M | -56.16M | -44.35M | -61.05M | -88.85M | -124.15M | -105.13M | -47.09M | -58.76M | -56.83M | -46.28M | -19.13M | -5.51M | -9.41M | -6.68M | -4.12M | -2.98M | -1.20M |
| Interest capitalized | — | 0 | — | — | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 1.17M | 6.84M | 26.83M | -17.15M | -7.74M | 12.43M | 8.22M | -39.44M | 30.30M | 83.14M | 177.20M | 229.72M | 325.80M | 300.65M | 111.24M | 73.40M | 12.17M | 79.35M | 210.49M | 106.24M |
| Non-operating interest income | 810.63K | 1.49M | 3.68M | 1.98M | 1.20M | 1.08M | 1.46M | 2.35M | 14.72M | 23.39M | 24.79M | 6.89M | 8.91M | 11.15M | 132.13M | 69.79M | 11.26M | 64.16M | 164.25M | 55.99M |
| Miscellaneous non-operating expense | 362.26K | 5.35M | 23.14M | -19.14M | -8.94M | 11.35M | 6.76M | -41.79M | 15.57M | 59.75M | 149.70M | 221.39M | 313.98M | 286.59M | -23.79M | -2.34M | -156.00K | 14.63M | 46.23M | 50.25M |
| Unusual income/expense | — | — | — | — | -5.05M | — | -97.37M | — | -2.33M | — | 945.00K | 3.36M | 529.00K | 911.00K | 304.00K | 0 | 36.43M | 61.83M | 74.68M | 0 |
| Pretax income | 64.42M | 106.30M | 62.07M | 49.81M | 37.06M | 32.54M | 91.42M | 328.52M | 2.03B | 1.52B | 975.84M | 1.23B | 1.96B | 1.56M | -1.06B | -774.74M | -1.22B | -1.18B | -1.06B | -1.61B |
| Taxes | -545.13K | 6.34M | 21.46M | 21.41M | 32.95M | 71.45M | 52.21M | -20.13M | -585.80M | -428.04M | -257.36M | -358.83M | -718.38M | -240.60M | 121.83M | 53.23M | 0 | 0 | 10.02M | 0 |
| Non-controlling/minority interest | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| After tax other income/expense | — | 0 | — | — | — | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 63.87M | 112.64M | 83.53M | 71.22M | 70.01M | 104.00M | 143.62M | 308.39M | 1.44B | 1.09B | 718.49M | 871.87M | 1.24B | -239.04M | -942.18M | -721.51M | -1.22B | -1.18B | -1.05B | -1.61B |
| Net income | 63.87M | 112.64M | 83.53M | 71.22M | 70.01M | 104.00M | 143.62M | 308.39M | 1.44B | 1.09B | 718.49M | 871.87M | 1.24B | -239.04M | -942.18M | -721.51M | -1.22B | -1.18B | -1.05B | -1.61B |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 63.87M | 112.64M | 83.53M | 71.22M | 70.01M | 104.00M | 143.62M | 308.39M | 1.44B | 1.09B | 718.49M | 871.87M | 1.24B | -239.04M | -942.18M | -721.51M | -1.22B | -1.18B | -1.05B | -1.61B |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 123.69M | 163.19M | 125.52M | 173.54M | 147.11M | 135.62M | 329.40M | 596.78M | 2.22B | 1.73B | 1.10B | 1.33B | 1.92B | -138.89M | -1.13B | -795.27M | -1.22B | -1.25B | -1.28B | -1.65B |
| EBIT | 76.23M | 122.84M | 80.96M | 123.12M | 94.20M | 81.17M | 269.42M | 492.12M | 2.10B | 1.48B | 856.46M | 1.06B | 1.68B | -280.86M | -1.17B | -838.73M | -1.26B | -1.32B | -1.34B | -1.71B |
| Total operating expenses | -804.55M | -996.32M | -1.09B | -1.28B | -1.20B | -1.42B | -1.77B | -2.09B | -3.00B | -3.73B | -4.14B | -4.33B | -4.45B | -3.04B | -1.31B | -973.51M | -1.38B | -1.46B | -1.46B | -1.78B |
| Prepaid expenses | 76.19M | 117.39M | 123.78M | 12.50M | 17.70M | 23.34M | 54.34M | 109.56M | 9.35M | 48.19M | 1.11B | 989.08M | 44.54M | 4.93M | 8.85M | 4.12M | 4.33M | 3.65M | 5.90M | 10.02M |
| Deferred income, current | — | — | — | — | — | — | — | — | 30.56M | — | 48.33M | 76.48M | 82.35M | 337.00K | 100.00K | 186.00K | 0 | 6.00K | 0 | — |
| Capital and operating lease obligations | 215.76K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29.35M | 29.35M | 3.92M | 15.73M | 5.79M | 0 | 0 |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 71.53M | 52.84M | 238.84M | 244.99M | 243.95M | 231.92M | 252.23M | 259.84M | 297.46M | 254.56M | 388.26M | 484.36M | 563.79M | 217.03M | 68.57M | — | — | — | — | — |
| Deferred income, non-current | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | — | — | — | — | — |
| Minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in accrued expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | -25.00M | -28.51M | -33.71M | -33.84M | -33.89M | -33.98M | -33.92M | -40.70M | -41.01M | -341.71M | -398.31M | -153.19M | -229.80M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends paid | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800